SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-154209
Filing Date
2017-05-02
Accepted
2017-05-02 17:14:57
Documents
66
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d372243d10q.htm 10-Q 459043
2 EX-10.1 d372243dex101.htm EX-10.1 1135456
3 EX-31.1 d372243dex311.htm EX-31.1 9233
4 EX-31.2 d372243dex312.htm EX-31.2 9272
5 EX-32.1 d372243dex321.htm EX-32.1 5443
  Complete submission text file 0001193125-17-154209.txt   3907569

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lnth-20170331.xml EX-101.INS 415538
7 XBRL TAXONOMY EXTENSION SCHEMA lnth-20170331.xsd EX-101.SCH 39760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lnth-20170331_cal.xml EX-101.CAL 68781
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lnth-20170331_def.xml EX-101.DEF 111074
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20170331_lab.xml EX-101.LAB 293723
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20170331_pre.xml EX-101.PRE 205310
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 17806114
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences